Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial.
Menne, Jan; Farsang, Csaba; Deák, László; Klebs, Sven; Meier, Matthias; Handrock, Renate; Sieder, Christian; Haller, Hermann.
; 26(9): 1860-7, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18698222
Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention.
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.
Probucol combined with valsartan in immunoglobulin A nephropathy: a multi-centre, open labelled, randomized controlled study.
Efficacy and safety of valsartan and amlodipine single-pill combination in hypertensive patients (PEAK study).
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg.
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions.
Post-marketing surveillance study of valsartan/amlodipine combination in Taiwanese hypertensive patients.
Enhanced cardiovascular protective effects of valsartan in high-risk hypertensive patients with left ventricular hypertrophy--sub-analysis of the KYOTO HEART study.
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.